CN1436557A - Disinfectant - Google Patents
Disinfectant Download PDFInfo
- Publication number
- CN1436557A CN1436557A CN 02113331 CN02113331A CN1436557A CN 1436557 A CN1436557 A CN 1436557A CN 02113331 CN02113331 CN 02113331 CN 02113331 A CN02113331 A CN 02113331A CN 1436557 A CN1436557 A CN 1436557A
- Authority
- CN
- China
- Prior art keywords
- concentration
- iodine
- benzoic acid
- add
- bactericide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000645 desinfectant Substances 0.000 title abstract 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims abstract description 30
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 29
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 15
- 239000005711 Benzoic acid Substances 0.000 claims abstract description 15
- 235000010233 benzoic acid Nutrition 0.000 claims abstract description 15
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 8
- 241000221079 Euphorbia <genus> Species 0.000 claims description 15
- 230000000844 anti-bacterial effect Effects 0.000 claims description 15
- 239000003899 bactericide agent Substances 0.000 claims description 13
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 9
- 229910052740 iodine Inorganic materials 0.000 claims description 9
- 239000011630 iodine Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- DKNPRRRKHAEUMW-UHFFFAOYSA-N Iodine aqueous Chemical compound [K+].I[I-]I DKNPRRRKHAEUMW-UHFFFAOYSA-N 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 13
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 230000007803 itching Effects 0.000 abstract description 3
- 229920000832 Cutin Polymers 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241001503991 Consolida Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 229960004365 benzoic acid Drugs 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 229960004839 potassium iodide Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 description 15
- 230000001954 sterilising effect Effects 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 9
- 201000004647 tinea pedis Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- -1 soak after 5-7 days Substances 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 108010084652 homeobox protein PITX1 Proteins 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940070384 ventolin Drugs 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The disinfectant consists of rocket consolida extractive, flavescent sophora root extractive, iodine, potassium iodide, benzoic acid, salicylic acid, borneol and medicinal alcohol. It is a combination of traditional Chinese medicine and Western medicine, and has the functions of killing bacteria, anticorrosion, eliminating wetness, stopping itching, astringing, eliminating bad smell, dissolving or softening skin cutin in sole and promting growth of newly growing skin. It has stable and high treating effect and no toxic side effect.
Description
The present invention relates to a kind of bactericide, the especially a kind of Dakin solution that can kill pathogenic bacterium such as fungus.
Beriberi that tinea pedis promptly is commonly called as or tinea pedis, it is because of pathogenic fungus infects due to the pedal skin, and is the most common in tinea.Because this sick cardinal symptom is very to itch incomparably, regular meeting makes the patient go to scratch the affected part with hands, and pathomycete infects the source of infection that finger forms other positions of health; Besides also can be infected when the articles for daily uses such as the used slippers of contact tinea patient, towel, bathtubs, therefore, the tinea pedis disease is again a kind of infectious disease.Though it is multiple that the medicine of existing treatment tinea pedis disease has, but still can not eliminate this transmission of disease, therefore, be necessary prior art is improved.
The object of the present invention is to provide a kind of have sterilization, sterilization, deodorization, antipruritic and can soften vola portion cutin, eliminate the bactericide of foot abnormal flavour.
Bactericide provided by the invention is made up of the raw material of following weight portion:
Garden euphorbia herb 150-300 part,
Radix Sophorae Flavescentis 100-250 part,
Iodine 1-5 part,
Potassium iodide 1-5 part,
Benzoic acid 10-20 part,
Salicylic acid 10-20 part,
Borneolum Syntheticum 10-20 part,
Ethanol is an amount of.
The wherein little suffering of its nature and flavor of garden euphorbia herb, acid, little cold has heat-clearing and toxic substances removing, the effect of convergence itching relieving.
Its nature and flavor bitter cold of Radix Sophorae Flavescentis has the effect of heat clearing and damp drying, wind dispelling insecticide.Iodine has the effect of sterilization antiseptical, allocates the potassium iodide hydrotropy into, and its concentration is 0.1-0.5%.It is anticorrosion that salicylic acid has sterilization, the effect of dissolving skin keratin, and its concentration is 1-2%.Benzoic acid has the effect of sterilization antiseptical, and its concentration is 1-2%.Borneolum Syntheticum concentration is 1-2%.Percentage ratio of the present invention all is weight percentage.
Method for production of the present invention is: get above-mentioned garden euphorbia herb and Radix Sophorae Flavescentis, after cleaning is dried, be ground into powder, adding concentration is 75% medical ethanol, soaks 5-7 days, and it is standby to extract filtrate.In filtrate, add iodine and potassium iodide again, make the concentration of iodine reach 0.1-0.5%, and add salicylic acid, benzoic acid and Borneolum Syntheticum, make their concentration reach 1-2%, fully promptly get the medicinal liquid that sterilizes behind the mixing, it is sprayed on the affected part or is sprayed at the effect that can play disinfection in the footwear.
Other method of the present invention is: get above-mentioned garden euphorbia herb and Radix Sophorae Flavescentis, after cleaning is dried, be ground into powder, it is an amount of to add concentration and be 75% medical ethanol, add the iodine solution that concentration is 0.1-0.5% again, after concentration is salicylic acid, benzoic acid and the Borneolum Syntheticum solution of 1-2%, promptly get the mass that sterilizes with soft substrate mixing.This mass is coated in socks inner bottom part and side bottom, gets final product.Described soft substrate is the soft substrate based on medical ventolin.
The clinical use result of bactericide provided by the invention shows to have following advantage and effect:
1, it is on the basis of traditional medicine achievement, dissolved in the method for modern medicine and pharmacology, blending the east and the west, reach sterilization and anticorrosion, removing damp to relieve itching, the convergence hidroschesis, eliminate the foot abnormal flavour, dissolving or softening vola portion skin keratin improve the pedal skin microcirculation, activate immunity of organism, recover the normal effect of pedal skin;
2, use this medicine back foot part old skin surface that carries disease germs to come off naturally, the newborn epidermis ramp of its deep health is complete, and the skin after recovering is bright and clean satiny, and whole process does not have bad sensation, can not influence walking and normal life;
3, this medicine no side effects is easy to use, good stability, and its curative effect is fast, and cure rate reaches more than 90%.
Therefore, the present invention is a kind of comparatively ideal bactericide.
Be the bactericide that shows the present invention therapeutic effect to the tinea pedis disease, the present invention is through the clinical observation of 100 many cases systems, and select medical history, the state of an illness, age, different tinea pedis patient's 76 examples of sex and carry out clinical observation, 20-30 year patient 22 people wherein, 35-50 year patient 38 people, 55-65 year patient 16 people.
Its clinical symptoms shows as: 1, vesicle; 2, decortication; 3, very itch incomparably.
According to patient's oral account symptom and clinical symptoms, determine conditions of patients, formulate following therapeutic scheme according to each patient's the state of an illness respectively again:
Patients with mild is worn socks 1-3 days that are coated with this sterilization mass, and is promptly effective.
The patient with severe symptoms except that wearing the socks that are coated with this sterilization mass, also needs the sterilization medicinal liquid in affected part spraying the present invention, and the inner surface at wearing shoes sprays the sterilization medicinal liquid simultaneously, and 1-2 days take effect, and its effect is more obvious.
Criterion of therapeutical effect is as follows:
Complete: no longer include blister, no longer decortication, no scratchiness, and the skin surface that newly grows is comparatively bright and clean satiny.
Take a turn for the better: no longer include blister, no longer decortication, but scratchiness is arranged once in a while, the skin surface that newly grows is smooth.
After above-mentioned 76 routine tinea pedis patients being carried out 1-3 days treatment, have 70 people all to cure, 4 people take a turn for the better, and 2 people disease occurs once more because of cross infection, but after the continuous treatment through a week, no longer recurrence.
Embodiment 1
Earlier take by weighing garden euphorbia herb and the Radix Sophorae Flavescentis raw material of making powder: garden euphorbia herb 150 grams by following proportioning, Radix Sophorae Flavescentis 250 grams, adding concentration and be 75% medical ethanol makes it soak raw material, soak after 5-7 days, extract filtrate, in this filtrate, add each 5 gram of iodine and potassium iodide then, each 20 gram of salicylic acid and benzoic acid and Borneolum Syntheticum, add concentration again and be 75% medical ethanol to 1000ml, get 1000ml sterilization medicinal liquid after fully being mixed, wherein the concentration of iodine is 0.5%, and the concentration of salicylic acid and benzoic acid and Borneolum Syntheticum respectively is 2% gram.
Embodiment 2
Take by weighing garden euphorbia herb and the Radix Sophorae Flavescentis raw material of making powder by following proportioning: garden euphorbia herb 300 grams, Radix Sophorae Flavescentis 100 grams, adding concentration and be 75% medical ethanol makes it soak raw material, soak after 5-7 days, extract filtrate, in this filtrate, add each 1 gram of iodine and potassium iodide then, each 15 gram of salicylic acid and benzoic acid and Borneolum Syntheticum, add concentration again and be 75% medical ethanol to 1000ml, get 1000ml sterilization medicinal liquid after fully being mixed, wherein the concentration of iodine is 0.1%, and the concentration of salicylic acid, benzoic acid and Borneolum Syntheticum respectively is 1.5%.
Embodiment 3
Take by weighing garden euphorbia herb and the Radix Sophorae Flavescentis raw material of making powder by following proportioning: garden euphorbia herb 200 grams, hardship
Ginseng 150 grams, it is an amount of to add concentration and be 75% medical ethanol, each 3 gram of iodine and potassium iodide, each 20 gram of salicylic acid, Borneolum Syntheticum and benzoic acid, add medical soft substrate and medical ethanol furnishing 1000 gram sterilization masses again, it is coated in socks inner bottom part and side bottom, promptly become Bactericidal socks.
Embodiment 4
Take by weighing garden euphorbia herb and the Radix Sophorae Flavescentis raw material of making powder by following proportioning: garden euphorbia herb 200 grams, Radix Sophorae Flavescentis 200 grams, it is an amount of to add concentration and be 75% medical ethanol, each 4 gram of iodine and potassium iodide, each 10 gram of salicylic acid, Borneolum Syntheticum and benzoic acid, add medical soft substrate and medical ethanol furnishing 1000 gram sterilization masses again, it is coated in socks inner bottom part and side bottom, promptly become Bactericidal socks.
Claims (4)
1, a kind of bactericide is characterized in that it is made up of the raw material of following weight portion:
Garden euphorbia herb 150-300 part,
Radix Sophorae Flavescentis 100-250 part,
Iodine 1-5 part,
Potassium iodide 1-5 part,
Benzoic acid 10-20 part,
Salicylic acid 10-20 part,
Borneolum Syntheticum 10-20 part,
Ethanol is an amount of.
2, bactericide according to claim 1 is characterized in that the concentration of iodine and potassium iodide is 0.1-0.5% in the medicine, and the concentration of salicylic acid, benzoic acid and Borneolum Syntheticum is 1-2%.
3, bactericide according to claim 1 is characterized in that described bactericide prepares by following method: get garden euphorbia herb and Radix Sophorae Flavescentis, after cleaning is dried, be ground into powder, adding concentration is 75% medical ethanol, soaks 5-7 days, and it is standby to extract filtrate; In filtrate, add iodine and potassium iodide again, make the concentration of iodine reach 0.1-0.5%, and add salicylic acid, benzoic acid and Borneolum Syntheticum, make their concentration reach 1-2%, fully promptly get the medicinal liquid that sterilizes behind the mixing.
4, bactericide according to claim 1, it is characterized in that described bactericide prepares by following method: get garden euphorbia herb and Radix Sophorae Flavescentis, after cleaning is dried, be ground into powder, it is an amount of to add concentration and be 75% medical ethanol, add the iodine solution that concentration is 0.1-0.5% again, after concentration is salicylic acid, benzoic acid and the Borneolum Syntheticum solution of 1-2%, promptly get the mass that sterilizes with soft substrate mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02113331 CN1183934C (en) | 2002-02-03 | 2002-02-03 | Disinfectant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02113331 CN1183934C (en) | 2002-02-03 | 2002-02-03 | Disinfectant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1436557A true CN1436557A (en) | 2003-08-20 |
| CN1183934C CN1183934C (en) | 2005-01-12 |
Family
ID=27628408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02113331 Expired - Fee Related CN1183934C (en) | 2002-02-03 | 2002-02-03 | Disinfectant |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1183934C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100344292C (en) * | 2005-01-21 | 2007-10-24 | 张拴成 | Injection for treating facial tic |
| CN100415100C (en) * | 2006-07-06 | 2008-09-03 | 王德昌 | Active disinfectant germicide and method for preparing same |
| CN101947253A (en) * | 2010-09-29 | 2011-01-19 | 哈尔滨乐泰药业有限公司 | External compound preparation for curing tinea corporis as well as preparation method and content measuring method thereof |
| CN103301189A (en) * | 2013-06-09 | 2013-09-18 | 万强胜 | Medicine for treating seborrhea |
| CN106309544A (en) * | 2015-06-24 | 2017-01-11 | 赵耀芳 | Chinese and Western medicine composition used for treating erosive beriberi and preparation method thereof |
| CN107513014A (en) * | 2016-06-17 | 2017-12-26 | 佛山市正典生物技术有限公司 | A kind of salicylic acid-iodine complex compound, preparation method and application |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101810198B (en) * | 2010-05-06 | 2015-01-28 | 佛山市正典生物技术有限公司 | Salicylic acid-iodine disinfector and preparation method thereof |
-
2002
- 2002-02-03 CN CN 02113331 patent/CN1183934C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100344292C (en) * | 2005-01-21 | 2007-10-24 | 张拴成 | Injection for treating facial tic |
| CN100415100C (en) * | 2006-07-06 | 2008-09-03 | 王德昌 | Active disinfectant germicide and method for preparing same |
| CN101947253A (en) * | 2010-09-29 | 2011-01-19 | 哈尔滨乐泰药业有限公司 | External compound preparation for curing tinea corporis as well as preparation method and content measuring method thereof |
| CN101947253B (en) * | 2010-09-29 | 2011-09-28 | 哈尔滨乐泰药业有限公司 | External compound preparation for curing tinea corporis as well as preparation method and content measuring method thereof |
| CN103301189A (en) * | 2013-06-09 | 2013-09-18 | 万强胜 | Medicine for treating seborrhea |
| CN103301189B (en) * | 2013-06-09 | 2016-01-20 | 万强胜 | A kind of medicine for the treatment of tinea capitis |
| CN106309544A (en) * | 2015-06-24 | 2017-01-11 | 赵耀芳 | Chinese and Western medicine composition used for treating erosive beriberi and preparation method thereof |
| CN107513014A (en) * | 2016-06-17 | 2017-12-26 | 佛山市正典生物技术有限公司 | A kind of salicylic acid-iodine complex compound, preparation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1183934C (en) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100512869C (en) | Chinese medicine for treating tinea pedis by soaking feet | |
| CN101991688A (en) | Application of medicinal composition to the preparation of medicament for treating diabetic ulcers | |
| CN101972460B (en) | Composition for treating beriberi and preparation method thereof | |
| CN1183934C (en) | Disinfectant | |
| US8591960B2 (en) | Composition and method for treating bedsores, cuts and burns | |
| CN105687021A (en) | Foot powder for preventing tinea pedis | |
| CN109731040A (en) | A kind of wound remediation composition, preparation method and applications | |
| RU2751810C1 (en) | Method for treatment of chronic periodontitis | |
| CN1032733C (en) | Foot-odor removing spray agent | |
| CN1628757A (en) | Externally applied healthy medicinal formulation | |
| CN101380316A (en) | Multifunctional external antibiotic preparation and production method thereof | |
| CN1927276A (en) | Foot odor and beriberi curing powder and method for making same | |
| CN104784534B (en) | A kind of prevention hand-foot-and-mouth disease hand cleanser | |
| CN100337677C (en) | Cassia oil composition and its application in making medicine | |
| CN108635362A (en) | A kind of pharmaceutical composition for treating diabetes | |
| CN1076613C (en) | Skin-cleaning sterilizing agent (Ziguang oil) | |
| CN1861092A (en) | Application of chlorine-contg. disinfectant in pharmaceutics | |
| CN1078147A (en) | A kind of preparation method of liquid for treating tinea pedis and foot odour | |
| CN1268349C (en) | Water soluble medicament for anti inflammation, repressing bacteria, eliminating pes off smell and treating asjike, and its application | |
| CN1615967A (en) | Chinese herbal medicine for treating beri-beri | |
| CN113116984A (en) | Herbal formula for treating beriberi | |
| CN1196180A (en) | Wide-spectrum disinfectant | |
| CN100382835C (en) | Disinfectant liquid for treating hand/foot tinea | |
| CN1257733C (en) | Skin and mueosa tissue disinfectant and its processing method | |
| WO2015159206A1 (en) | Copper alloy microparticles for use in the treatment of an external skin lesion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: KUNMING ZHIQIANG PHARMA CO., LTD. Free format text: FORMER OWNER: SHEN ZHIQIANG Effective date: 20120618 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650031 KUNMING, YUNNAN PROVINCE TO: 650106 KUNMING, YUNNAN PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120618 Address after: 650106 No. 2682, Yunnan Burma Road, Yunnan, Kunming Patentee after: Kunming Zhiqiang Pharmaceutical Co. Ltd. Address before: 650031 Huang Qiang, electrocardiogram room, first people's Hospital of Qingnian Road extension hospital, Yunnan, Kunming, China Patentee before: Shen Zhiqiang |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050112 Termination date: 20130203 |